193 related articles for article (PubMed ID: 37078697)
1. Subpleural fibrotic interstitial lung abnormalities are implicated in non-small cell lung cancer radiotherapy outcomes.
Ito M; Katano T; Okada H; Sakuragi A; Minami Y; Abe S; Adachi S; Oshima Y; Ohashi W; Kubo A; Fukui T; Ito S; Suzuki K
Radiol Oncol; 2023 Jun; 57(2):229-238. PubMed ID: 37078697
[TBL] [Abstract][Full Text] [Related]
2. Effect of Interstitial Lung Abnormality on Concurrent Chemoradiotherapy-treated Stage III Non-small Cell Lung Cancer Patients.
Jeong WG; Kim YH; Ahn SJ; Jeong JU; Lee BC; Cho IJ; Kim YH
Anticancer Res; 2023 Apr; 43(4):1797-1807. PubMed ID: 36974810
[TBL] [Abstract][Full Text] [Related]
3. Preexisting radiological interstitial lung abnormalities are a risk factor for severe radiation pneumonitis in patients with small-cell lung cancer after thoracic radiation therapy.
Li F; Zhou Z; Wu A; Cai Y; Wu H; Chen M; Liang S
Radiat Oncol; 2018 May; 13(1):82. PubMed ID: 29716649
[TBL] [Abstract][Full Text] [Related]
4. Radiologic-pathologic correlation of interstitial lung abnormalities and predictors for progression and survival.
Chae KJ; Chung MJ; Jin GY; Song YJ; An AR; Choi H; Goo JM
Eur Radiol; 2022 Apr; 32(4):2713-2723. PubMed ID: 34984519
[TBL] [Abstract][Full Text] [Related]
5. Automated CT quantification of interstitial lung abnormality and interstitial lung disease according to the Fleischner Society in patients with resectable lung cancer: prognostic significance.
Ahn Y; Lee SM; Choi S; Lee JS; Choe J; Do KH; Seo JB
Eur Radiol; 2023 Nov; 33(11):8251-8262. PubMed ID: 37266656
[TBL] [Abstract][Full Text] [Related]
6. Impact of Baseline Interstitial Lung Abnormalities on Pneumonitis Risk in Patients Receiving Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer.
Petranovic M; McDermott S; Mercaldo S; Little BP; Graur A; Huang K; Fintelmann FJ; Digumarthy SR; Gainor JF
Clin Lung Cancer; 2023 Dec; 24(8):682-688.e5. PubMed ID: 37758549
[TBL] [Abstract][Full Text] [Related]
7. Association between interstitial lung abnormality and mortality in patients with esophageal cancer.
Hata A; Yanagawa M; Miyata T; Hiraoka Y; Shirae M; Ninomiya K; Doi S; Yamagata K; Yoshida Y; Kikuchi N; Ogawa R; Hatabu H; Tomiyama N
Jpn J Radiol; 2024 Apr; ():. PubMed ID: 38658500
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and risk factors for interstitial lung disease spreading in low-dose irradiated areas after definitive radiotherapy with or without durvalumab consolidation therapy for patients with non-small cell lung cancer.
Sakagami M; Inokuchi H; Mukumoto N; Itoyama H; Hamaura N; Yamagishi M; Mukumoto N; Matsuda S; Kabata D; Shibuya K
Radiat Oncol; 2023 May; 18(1):87. PubMed ID: 37217919
[TBL] [Abstract][Full Text] [Related]
9. Chemoradiotherapy for locally advanced lung cancer patients with interstitial lung abnormalities.
Higo H; Kubo T; Makimoto S; Makimoto G; Ihara H; Masaoka Y; Ninomiya T; Ichihara E; Ohashi K; Sato A; Hotta K; Tabata M; Takigawa N; Maeda Y; Kiura K
Jpn J Clin Oncol; 2019 May; 49(5):458-464. PubMed ID: 30793176
[TBL] [Abstract][Full Text] [Related]
10. Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities.
Kobayashi H; Wakuda K; Naito T; Mamesaya N; Omori S; Ono A; Kenmotsu H; Murakami H; Endo M; Harada H; Gon Y; Takahashi T
Radiat Oncol; 2021 Mar; 16(1):52. PubMed ID: 33731123
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for radiation pneumonitis in lung cancer patients with subclinical interstitial lung disease after thoracic radiation therapy.
Li F; Liu H; Wu H; Liang S; Xu Y
Radiat Oncol; 2021 Apr; 16(1):70. PubMed ID: 33849579
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and prognostic meaning of interstitial lung abnormalities in remote CT scans of patients with interstitial lung disease treated with antifibrotic therapy.
García Mullor MM; Arenas-Jiménez JJ; Ureña Vacas A; Gayá García-Manso I; Pérez Pérez JL; Serra Serra N; García Sevila R
Radiologia (Engl Ed); 2024 Apr; 66 Suppl 1():S10-S23. PubMed ID: 38642956
[TBL] [Abstract][Full Text] [Related]
13. Survival impact of fibrotic interstitial lung abnormalities in resected stage IA non-small cell lung cancer.
Jeong WG; Kim YH
Br J Radiol; 2023 Aug; 96(1148):20220812. PubMed ID: 37191186
[TBL] [Abstract][Full Text] [Related]
14. Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancer.
Nakanishi Y; Masuda T; Yamaguchi K; Sakamoto S; Horimasu Y; Nakashima T; Miyamoto S; Tsutani Y; Iwamoto H; Fujitaka K; Miyata Y; Hamada H; Okada M; Hattori N
Respir Investig; 2019 Sep; 57(5):451-459. PubMed ID: 31248832
[TBL] [Abstract][Full Text] [Related]
15. Newly diagnosed non-small cell lung cancer with interstitial lung abnormality: Prevalence, characteristics, and prognosis.
Zhu M; Yi J; Su Y; Zhang Y; Gao Y; Xu X; Zhang S; Zhang Y; Huang K
Thorac Cancer; 2023 Jul; 14(19):1874-1882. PubMed ID: 37232276
[TBL] [Abstract][Full Text] [Related]
16. Interstitial lung abnormalities and interstitial lung diseases associated with cigarette smoking in a rural cohort undergoing surgical resection.
Sangani RG; Deepak V; Ghio AJ; Forte MJ; Zulfikar R; Patel Z; King A; Alshaikhnassir E; Abbas G; Vos J
BMC Pulm Med; 2022 Apr; 22(1):172. PubMed ID: 35488260
[TBL] [Abstract][Full Text] [Related]
17. Interstitial Lung Abnormalities at CT: Subtypes, Clinical Significance, and Associations with Lung Cancer.
Hata A; Hino T; Yanagawa M; Nishino M; Hida T; Hunninghake GM; Tomiyama N; Christiani DC; Hatabu H
Radiographics; 2022; 42(7):1925-1939. PubMed ID: 36083805
[No Abstract] [Full Text] [Related]
18. Practice patterns in reporting interstitial lung abnormality at a tertiary academic medical center.
Escalon JG; Podolanczuk AJ; Aronson KI; Legasto AC; Gruden JF; Lynch DA; Rachid L; Rabkova Y; Steinberger S
Clin Imaging; 2023 Dec; 104():109996. PubMed ID: 37862912
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of interstitial lung abnormalities and immune checkpoint inhibitor-induced interstitial lung disease in patients with non-small cell lung cancer.
Murata D; Azuma K; Matama G; Zaizen Y; Matsuo N; Murotani K; Tokito T; Hoshino T
Thorac Cancer; 2023 Jan; 14(1):73-80. PubMed ID: 36377039
[TBL] [Abstract][Full Text] [Related]
20. Impact of palliative radiotherapy with or without lung irradiation in patients with interstitial lung disease.
Makita K; Hamamoto Y; Kanzaki H; Nagasaki K; Sugawara Y; Kozuki T
Radiother Oncol; 2023 Jun; 183():109636. PubMed ID: 36963439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]